Enzymatic Creatinine Assay (265 Series)
Enzymatic Method, Creatinine. 510(k) K070383, from Diagnostic Chemicals , Ltd. (Charlottetown, P.E., CA). Product code JFY, class 2.
As of Nov 19, 2026, K070383 is an FDA 510(k) held by Diagnostic Chemicals , Ltd., substantially equivalent on Jun 22, 2007 after 133 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 133 days
- Recalls: 2
- Cited as a predicate by: 1 device
- Creatinine PlusK003261 · Roche Diagnostics Corp. · Nov 16, 2000
- Abx Pentra Enzymatic Creatinine CP, Abx Pentra Multical, Abx Pentra N Control, Abx Pentra P Control, and Abx Pentra UrinK110137 · Horiba Abx SAS · Aug 10, 2011
| Started | Recall | Status |
|---|---|---|
| Feb 12, 2009 | Z-2326-2009, Z-2327-2009Labeled with extended expiration date (24 months instead of 18 months) | Terminated |
- Qscheck UisacrK252619 · Qstag, Inc. · Feb 20, 2026
- Atellica CH Enzymatic Creatinine_3 (ECre3)K212223 · Siemens Healthcare Diagnostics, Inc. · Nov 24, 2021
- Yumizen C1200 Creatinine PAPK193649 · Horiba Abx SAS · May 10, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 9, 2007
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files